Pashtoon Kasi, MD, MS

Older Patients With Metastatic Colorectal Cancer: Real-World Experience in the US

Please join Pashtoon Kasi, MD, MS, from Weill Cornell Medicine and Englander Institute of Precision Medicine, as he discusses pivotal presentations from ASCO 2023 focused on metastatic colorectal cancer (mCRC). Read More ›

Targeted Therapy Investigations: Study Outcomes and Designs in mCRC

Please join Pashtoon Kasi, MD, MS, from Weill Cornell Medicine and Englander Institute of Precision Medicine, as he discusses the trends and outcomes of older patients compared to younger patients who received 1L chemotherapy for mCRC. Read More ›

Biomarker Testing in mCRC to Help Identify Appropriate Patients for Targeted Treatment

Please join Pashtoon Kasi, MD, MS, from Weill Cornell Medicine and Englander Institute of Precision Medicine, as he describes the outcomes and study design of clinical trials evaluating targeted therapeutic options for patients with mCRC. Read More ›